Skip to main content
. Author manuscript; available in PMC: 2014 Jan 1.
Published in final edited form as: Cancer. 2012 Jun 26;119(1):7–15. doi: 10.1002/cncr.27608

Table 1.

Patient and Tumor Characteristics

ALL MET copy number PI3KCA copy number
Characteristic N=971 % High Normal/Low P-value High Normal/Lost P-value
N=82 % N=889 % N=134 % N=837
Age at Diagnosis
Min 25 -- 28 -- 25 -- 25 -- 25 --
Median 53 -- 52 -- 53.5 -- 51 -- 54 --
Max 87 -- 86 -- 87 -- 0.3899 84 -- 87 -- 0.0387
Tumor size
<2cm 566 58.29 34 41.46 532 59.84 62 46.27 504 60.22
>=2cm 369 38 46 56.1 323 36.33 0.0009 69 51.49 300 35.84 0.0012
Nodal Status
Positive 383 39.44 34 41.46 349 39.26 38 28.36 345 41.22
Negative 565 58.19 47 57.32 518 58.27 0.8543 93 69.4 472 56.39 0.0057
Grade
1 92 9.47 4 4.88 88 9.9 5 3.73 87 10.39
2 477 49.12 35 42.68 442 49.72 50 37.31 427 51.02
3 336 34.6 41 50 295 33.18 0.0153 72 53.73 264 31.54 <0.0001
Estrogen Receptor
Negative 293 30.18 38 46.34 255 28.68 71 52.99 222 26.52
Positive 666 68.59 44 53.66 622 69.97 0.0018 62 46.27 604 72.16 <0.0001
Progesterone Receptor
Negative 406 41.81 42 51.22 364 40.94 80 59.7 326 38.95
Positive 555 57.16 40 48.78 515 57.93 0.109 53 39.55 502 59.98 <0.0001
HER2
Negative 764 78.68 68 82.93 696 78.29 102 76.12 662 79.09
Positive 207 21.32 14 17.07 193 21.71 0.4009 32 23.88 175 20.91 0.5051
Breast Cancer Subtype
HER2-positive 207 21.32 14 17.07 193 21.71 32 23.88 175 20.91
Hormone receptor-positive 583 60.04 44 53.66 539 60.63 53 39.55 530 63.32
Triple receptor negative 173 17.82 24 29.27 149 16.76 0.0193 49 36.57 124 14.81 <0.0001
Menopausal Status
Peri/pre-menopausal 312 32.13 28 34.15 284 31.95 49 36.57 263 31.42
Post-menopausal 624 64.26 52 63.41 572 64.34 0.8363 80 59.7 544 64.99 0.2686
Stage
I 304 31.31 18 21.95 286 32.17 32 23.88 272 32.5
II 662 68.18 64 78.05 598 67.27 0.0694 101 75.37 561 67.03 0.0599
Histology
Ductal 898 92.48 78 95.12 820 92.24 128 95.52 770 92
Other 58 5.97 3 3.66 55 6.19 0.4914 2 1.49 56 6.69 0.0332
MET
High copy number 82 8.44 -- -- -- -- 21 15.67 61 7.29
Normal/Low copy number 889 91.56 -- -- -- -- -- 113 84.33 776 92.71 0.0021
PIK3CA
High copy number 134 13.8 21 25.61 113 12.71 -- -- -- --
Normal/Low copy number 837 86.2 61 74.39 776 87.29 0.0021 -- -- -- -- --
Chemotherapy
No 480 49.43 38 46.34 442 49.72 62 46.27 418 49.94
Anthracycline-based 323 33.26 26 31.71 297 33.41 49 36.57 272 32.74
Anthracycline and Taxane-based 114 11.74 12 14.63 102 11.47 0.6496 14 10.45 100 11.95 0.5961
Radiation Therapy
Yes 410 42.22 38 46.34 372 41.84 47 35.07 363 43.37
No 535 55.1 43 52.44 492 55.34 0.5805 84 62.69 451 53.88 0.0762
Endocrine Therapy
Yes 422 43.46 23 28.05 399 44.88 36 26.87 386 46.12
No 522 53.76 58 70.73 464 52.19 0.003 95 70.9 427 51.02 <0.0001